Table 3. Demographic and clinical characteristics of the six patients with prostate invasion, except for prostate cancer.
| Variable | Value |
|---|---|
| No. of patients | 6 |
| Age (y) | 59.0±12.9 |
| Serum PSA (ng/mL) | 3.2±3.4 |
| Prostate volume in TRUS (mL) | 49.3±25.6 |
| Maximum SUV | 6.2±3.0 |
| Distribution of lesion in PET | |
| Focal | 2 (33.3) |
| Diffuse | 4 (66.7) |
| Histology | |
| BCG-granuloma | 2 (33.3) |
| Lymphoma | 2 (33.3) |
| GIST | 1 (16.7) |
| Colon cancer | 1 (16.7) |
Values are presented as mean±standard deviation or number (%).
PSA, prostate-specific antigen; TRUS, transrectal ultrasonography; SUV, standardized uptake value; PET, positron emission tomography; BCG, bacillus Calmette-Guerin; GIST, gastrointestinal stromal tumor.